← Leaderboards
Sharron Erna Gargosky
Etirarx, Llc
$665,862
Attributed
$1,997,586
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2021–22$2M$1.5M$1M$500K$0
'21
'22
Funding mix
By agency
NIH$1,997,586 · 1
By mechanism
R44$1,997,586 · 1
Top collaborators
- Ganesh V Raj2 shared
- Ratna K Vadlamudi2 shared
Others in their field
Other Emerging Leaders on “Drug Design”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- John Damon Chodera · Sloan-Kettering Inst Can Research$53,982,083
- Yunda Huang · Fred Hutchinson Cancer Center$52,681,952
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
Drug DesignAnimalsAnalogDoseBenzamidesBindingAnimal ModelBiodistributionApoptoticBreast Cancer CellBreast Cancer Cell LineBreast Cancer ModelCanis FamiliarisCardiovascular SystemCell DeathCell GrowthCell LineClinical EfficacyClinically RelevantClinical TranslationClinical TrialsDesignDetectionDrug Kinetics